marcus evans europe conferences

3rd Annual Portfolio Management Strategies for Biosimilars & Generics

Acknowledge New Trends in Profitable Markets, Seek for Strategic Alliances to Improve Marketing and Commercial Strategies, Understand Stakeholder’s Opinions

26-27 September 2019
World Trade Center Barcelona, Spain

Conference Workshop

Exploring Markets, Obliterating Frontiers

Different countries’ dynamics and regulations transform market access into a hard task to complete. This workshop will help participants to employ tools and develop strategies to overcome these constraints. Additionally, it will discuss the possibility to develop products that meet the criteria for different regions.

Workshop Moderator: Michal Urban, Project Management & Launch Preparation Lead China & Emerging Markets GBU | Erez Hybloom, Former Senior Director, Global Portfolio and Europe Portfolio

Company: Sanofi & Teva


Why You Should Attend

3rd Annual Portfolio Management Strategies for Biosimilars & Generics

marcus evans’ upcoming 3d annual conference in Portfolio Management Strategies for Biosimilars and Generics bestows a place for pharmaceutical companies to share outlooks, concerns and impressions in a professional environment. We want to give you the means to apply new strategies to enter multiple markets with different regulations, strengthen commercial and marketing relationships, build strategic alliances, understand stakeholder's opinions and consider value-added generics and biosimilars markets to find less overcrowded and more profitable markets. This annual event will also provide you with a great chance to not only benchmark with big Pharma companies but with successful small/mid-size ones that are thriving in an extremely competitive market. We wish not only to create a professional environment but a distended atmosphere where attendees are able to schedule one-to-one meetings with our exceptional speakers and meet peers who are willing to discuss their strategies and approaches in highly interactive roundtables, panel discussions and workshops.”

“The latest updates show that not many blockbuster drug's patents are about to expire and only a few companies in the top 20 generics market had a positive growth in the last year. The generics' market faces a stagnant future landscape. In this grey scenery, it is high time that pharmaceutical companies look after their portfolio.


Key Topics

  • Gedeon Ritcher discussing the best marketing practices
  • Biocon evaluating the power of strategic alliances
  • Accord Healthcare bringing together portfolio and project management
  • CSA Healthcare evaluating the criteria for driving high valuable portfolios
  • Previous Attendees Include

    • ABBOTT LABORATORIES
    • ABBVIE
    • ASTELLAS
    • ACTELION
    • ASTRAZENECA
    • ALMIRALL
    • AMGEN
    • ASTELLAS
    • BAXALTA
    • BAXTER
    • BAYER
    • BIOGEN IDEC
    • BRISTOL-MYERS SQUIBB
    • BOEHRINGER INGELHEIM
    • CELGENE
    • CHIESI FARMACEUTICI SPA
    • ELI LILLY
    • GLAXOSMITHKLINE
    • IPSEN
    • JANSSEN PHARMACEUTICAL
    • JOHNSON & JOHNSON
    • MERCK
    • MITSUBISHI TANABE PHARMACEUTICALS
    • NOVARTIS
    • ORION CORPORATION
    • PFIZER
    • SANOFI-AVENTIS
    • SHIRE INTERNATIONAL
    • TAKEDA
    • TEVA PHARMACEUTICALS


    Why Choose marcus evans?

    marcus evans specialises in the research and development of strategic events for senior business executives. From our international network of 63 offices, marcus evans produces over 1000 event days a year on strategic issues in corporate finance, telecommunications, technology, health, transportation, capital markets, human resources and business improvement.

    Above all, marcus evans provides clients with business information and knowledge which enables them to sustain a valuable competitive advantage and makes a positive contribution to their success.




    Event Partners


    Practical Insights From

    Erez Hybloom
    Former Senior Director, Global Portfolio and Europe Portfolio
    Teva

    Amit Bansal
    Divestment Lead
    Sanofi

    Detlef Behrens
    Head of CMO
    Biocon

    Nicola Travierso
    President
    Velit Biopharmaceuticals

    Bjarni Baerings
    President
    Hetero

    Sameer Agarwal
    CEO
    CSA Healthcare

    Ana Gavaldá
    Managing Director
    Annion Pharma

    Joanna T. Brougher
    Founder & Principal
    BioPharma Law Group, PLLC

    Click Here For Full Agenda

    Voice of Our Customers
    • “The conference is well organised and speakers are all high quality!” - Programme Coordinator, J&J
    • “High quality speakers, enjoyed the networking” - VP, Debiopharm
    • “I appreciated the conference a lot, having the possibility to compare project management actions of my company with the other companies” - Project Manager R&D, Chiesi
    Latest Conference News & Resources



    Join the Discussion

    Follow on LinkedIn





    Event Contact

    For all enquiries regarding speaking, sponsoring and attending this conference contact:

    Constandinos Vinall


    marcus evans (Europe) Ltd
    PO Box 24797
    1304 Nicosia, Cyprus

    Telephone:
    +357 22849 380
    Fax: +357 22849 394
    Email: constandinosv@marcusevanscy.com